285 related articles for article (PubMed ID: 3486067)
1. Extractable nuclear antigen (ENA) autoantibodies in SLE: an immunogenetic relationship with HLA, C4 and Bf alleles.
Warlow RS; Uko G; McCluskey J; Kay PH; Christiansen FT; Dawkins RL
Clin Exp Immunol; 1986 Feb; 63(2):419-27. PubMed ID: 3486067
[TBL] [Abstract][Full Text] [Related]
2. HLA, C4, Bf, Gm and autoantibodies in rheumatoid arthritis.
Warlow RS; Uko G; Feeney DJ; Kay PH
Exp Clin Immunogenet; 1988; 5(2-3):133-42. PubMed ID: 3272816
[TBL] [Abstract][Full Text] [Related]
3. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
4. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
5. Interaction between certain major histocompatibility complex class II and T-cell receptor V beta alleles promotes the antibody production to extractable nuclear antigen-related peptides.
Youinou P; Semana G; Muller S; Piette JC; Guillevin L; Jouquan J; Salmon D; Salmon J; Genetet B; Bach JF
Hum Immunol; 1997 Jan; 52(1):12-21. PubMed ID: 9021405
[TBL] [Abstract][Full Text] [Related]
6. [HLA markers and complotypes: risk factors in systemic lupus erythematosus?].
Gougerot A; Stoppa-Lyonnet D; Poirier JC; Schmid M; Busson M; Marcelli A
Ann Dermatol Venereol; 1987; 114(3):329-34. PubMed ID: 3605963
[TBL] [Abstract][Full Text] [Related]
7. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
[TBL] [Abstract][Full Text] [Related]
8. Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus.
Reveille JD; Arnett FC; Wilson RW; Bias WB; McLean RH
Immunogenetics; 1985; 21(4):299-311. PubMed ID: 3873410
[TBL] [Abstract][Full Text] [Related]
9. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
Agarwal S; Harper J; Kiely PD
Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens.
Martins TB; Burlingame R; von Mühlen CA; Jaskowski TD; Litwin CM; Hill HR
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1054-9. PubMed ID: 15539505
[TBL] [Abstract][Full Text] [Related]
11. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens.
Warlow R; Carrano J; Dawkins R
Diagn Immunol; 1984; 2(3):154-60. PubMed ID: 6437732
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens associated with systemic lupus erythematosus in Japan.
Hashimoto H; Tsuda H; Matsumoto T; Nasu H; Takasaki Y; Shokawa Y; Hirose S; Terasaki PI; Iwaki Y
J Rheumatol; 1985 Oct; 12(5):919-23. PubMed ID: 3878879
[TBL] [Abstract][Full Text] [Related]
13. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tanned cell hemagglutination and counter immunoelectrophoresis test in the detection of antibodies to extractable nuclear antigens (ENA) and to DNA in the systemic lupus erythematosus.
Depiante-Depaoli M; Galmarini M; Pesoa SA; Riera CM
Ann Biol Clin (Paris); 1989; 47(5):247-51. PubMed ID: 2787132
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
16. Subsets of autoantibodies to extractable nuclear antigens (ENA) as assayed by ELISA correlate with specific clinical abnormalities in SLE.
Warlow RS
Scand J Rheumatol; 1986; 15(1):57-67. PubMed ID: 2421399
[TBL] [Abstract][Full Text] [Related]
17. [Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers].
Specker C; Lakomek HJ; Kuntz BM; Bremer G; Goerz G; Krüskemper HL
Dtsch Med Wochenschr; 1987 Apr; 112(15):577-80. PubMed ID: 3493893
[TBL] [Abstract][Full Text] [Related]
18. Bf and C4 phenotypes in patients with psoriasis.
Wyatt RJ; Wang C; Hudson EC; Jones RM; Noah PW; Rosenberg EW
Acta Derm Venereol Suppl (Stockh); 1989; 146():211-3. PubMed ID: 2609873
[TBL] [Abstract][Full Text] [Related]
19. Antibody to extractable nuclear antigen in the rheumatic diseases.
McCain GA; Bell DA; Chodirker WB; Komar RR
J Rheumatol; 1978; 5(4):399-406. PubMed ID: 310883
[TBL] [Abstract][Full Text] [Related]
20. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
